0.613
0.16 (34.43%)
| Previous Close | 0.456 |
| Open | 0.620 |
| Volume | 12,352,276 |
| Avg. Volume (3M) | 5,827,843 |
| Market Cap | 15,737,418 |
| Price / Sales | 108.29 |
| Price / Book | 0.150 |
| 52 Weeks Range |
| Operating Margin (TTM) | -383.28% |
| Diluted EPS (TTM) | -0.540 |
| Quarterly Revenue Growth (YOY) | -16.40% |
| Quarterly Earnings Growth (YOY) | -30.50% |
| Total Debt/Equity (MRQ) | 3.61% |
| Current Ratio (MRQ) | 0.250 |
| Operating Cash Flow (TTM) | -1.75 M |
| Return on Assets (TTM) | -11.32% |
| Return on Equity (TTM) | -18.52% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Biotechnology (US) | Mixed | Mixed |
| Biotechnology (Global) | Mixed | Mixed | |
| Stock | OSR Holdings, Inc. | - | - |
AIStockmoo Score
| Analyst Consensus | 0.0 |
| Insider Activity | NA |
| Price Volatility | -2.0 |
| Technical Moving Averages | 2.5 |
| Technical Oscillators | -2.5 |
| Average | -0.50 |
|
OSR Holdings Inc is a healthcare company dedicated to healthcare outcomes and improving the quality of life for people and their families. It builds and develops a robust portfolio of potentially transformative therapies and healthcare solutions. The business of the company includes developing oral immunotherapies for the treatment of cancer, developing design-augmented biologics for age-related and other degenerative diseases, and neurovascular intervention medical device and systems distribution in Korea. |
|
| Sector | Healthcare |
| Industry | Biotechnology |
| % Held by Insiders | 62.40% |
| % Held by Institutions | 0.35% |
No data within this time range.
No data within this time range.
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2025 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |